ANGIODYNAMICS INC (ANGO) Stock Price, Quote, News and Overview
NASDAQ:ANGO - Nasdaq - US03475V1017 - Common Stock - Currency: USD
ANGO Quote, Performance and Key Statistics
10.33
-0.26 (-2.46%)
The current stock price of ANGO is 10.33 USD. In the past month the price decreased by -17.03%. In the past year, price increased by 78.41%.
ANGO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About ANGO
Company Profile
AngioDynamics, Inc. operates as a medical device company, which engages in the development, manufacturing and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 748 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Company Info
ANGIODYNAMICS INC
14 Plaza Drive
Latham NEW YORK 12110 US
CEO: James C. Clemmer
Employees: 748
Company Website: https://www.angiodynamics.com/
Investor Relations: https://investors.angiodynamics.com/?us
Phone: 15187981215
ANGIODYNAMICS INC / ANGO FAQ
What is the stock price of ANGIODYNAMICS INC today?
The current stock price of ANGO is 10.33 USD. The price decreased by -2.46% in the last trading session.
What is the ticker symbol for ANGIODYNAMICS INC stock?
The exchange symbol of ANGIODYNAMICS INC is ANGO and it is listed on the Nasdaq exchange.
On which exchange is ANGO stock listed?
ANGO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ANGIODYNAMICS INC stock?
9 analysts have analysed ANGO and the average price target is 15.64 USD. This implies a price increase of 51.4% is expected in the next year compared to the current price of 10.33. Check the ANGIODYNAMICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ANGIODYNAMICS INC worth?
ANGIODYNAMICS INC (ANGO) has a market capitalization of 418.06M USD. This makes ANGO a Small Cap stock.
How many employees does ANGIODYNAMICS INC have?
ANGIODYNAMICS INC (ANGO) currently has 748 employees.
What are the support and resistance levels for ANGIODYNAMICS INC (ANGO) stock?
ANGIODYNAMICS INC (ANGO) has a support level at 10.32 and a resistance level at 10.89. Check the full technical report for a detailed analysis of ANGO support and resistance levels.
Is ANGIODYNAMICS INC (ANGO) expected to grow?
The Revenue of ANGIODYNAMICS INC (ANGO) is expected to decline by -2.68% in the next year. Check the estimates tab for more information on the ANGO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ANGIODYNAMICS INC (ANGO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ANGO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ANGO, evaluating the profitability, health, valuation and growth aspects
- ANGIODYNAMICS INC (ANGO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ANGIODYNAMICS INC (ANGO) Sales and EPS estimates to see what analysts future expectations are.
- ANGIODYNAMICS INC (ANGO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ANGIODYNAMICS INC (ANGO) Insider and Institutional Ownership to learn about the owners and their transactions.
- ANGIODYNAMICS INC (ANGO) Stock Chart to make your own analysis
- ANGIODYNAMICS INC (ANGO) Latest news and press-releases to stay up to date.
Does ANGIODYNAMICS INC (ANGO) stock pay dividends?
ANGO does not pay a dividend.
When does ANGIODYNAMICS INC (ANGO) report earnings?
ANGIODYNAMICS INC (ANGO) will report earnings on 2025-04-02, before the market open.
What is the Price/Earnings (PE) ratio of ANGIODYNAMICS INC (ANGO)?
ANGIODYNAMICS INC (ANGO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.37).
What is the Short Interest ratio of ANGIODYNAMICS INC (ANGO) stock?
The outstanding short interest for ANGIODYNAMICS INC (ANGO) is 3.85% of its float. Check the ownership tab for more information on the ANGO short interest.
ANGO Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ANGO. When comparing the yearly performance of all stocks, ANGO is one of the better performing stocks in the market, outperforming 95.71% of all stocks.
ANGO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ANGO. While ANGO seems to be doing ok healthwise, there are quite some concerns on its profitability.
ANGO Financial Highlights
Over the last trailing twelve months ANGO reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS decreased by -105.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -77.08% | ||
| ROE | -120.32% | ||
| Debt/Equity | 0 |
ANGO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to ANGO. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 3.23% and a revenue growth -2.68% for ANGO